Synnovation Therapeutics

Synnovation Therapeutics is a precision medicine company dedicated to developing small molecule therapies optimized for best-in-class pharmacology against highly validated disease targets. Their focus is on improving the lives of cancer patients through the development of innovative targeted therapies. Leveraging deep expertise in cancer biology and a world-class medicinal chemistry team, they have built a diverse pipeline of novel small molecule therapies. Their mission is to efficiently advance these agents into clinical trials with the goal of transforming cancer care through patient-focused precision medicine.

The company was founded by a highly experienced management team with a rich history of successful drug discovery. This team, originating from Incyte, has contributed to the development of five approved drugs for various diseases, including myelofibrosis, graft-vs-host disease, rheumatoid arthritis, and non-small-cell lung cancer. Synnovation's lead program, SNV1521, a PARP1 selective inhibitor, is currently in a Phase I study. The company is committed to developing breakthrough precision medicines that address significant unmet medical needs and ultimately improve patient outcomes.

Synnovation Therapeutics is a precision medicine company dedicated to developing small molecule therapies optimized to achieve best-in-class pharmacology against highly validated disease targets, specifically focusing on cancer. Their mission is to discover and develop novel, targeted therapies that improve the lives of people living with cancer by efficiently advancing these agents into clinical trials and ultimately transforming cancer care through patient-focused precision medicine.

Synnovation Therapeutics fosters a collaborative and diverse work environment where teamwork and a passion for science are paramount. They value ambition, open-mindedness, intellectual curiosity, and a dedication to improving patient lives. The company emphasizes the importance of its employees, recognizing them as crucial components of its success.

Synnovation Therapeutics is committed to fostering a diverse and inclusive work environment that values the contributions of all employees. They believe that a diverse team with a breadth of experience in both drug discovery and development is essential to their success. They seek individuals who are ambitious, open-minded, intellectually curious, and driven by a passion for science and improving the lives of patients. Synnovation is an equal opportunity employer and does not discriminate against any employee or applicant on the basis of protected characteristics.